Mark Jacobson, M.A
2021
In 2021, Mark Jacobson, M.A earned a total compensation of $4.8M as Chief Operating Officer at Axsome Therapeutics, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,060 |
|---|---|
| Option Awards | $3,240,166 |
| Salary | $409,000 |
| Stock Awards | $999,938 |
| Other | $6,660 |
| Total | $4,794,824 |
MA received $3.2M in option awards, accounting for 68% of the total pay in 2021.
MA also received $139.1K in non-equity incentive plan, $409K in salary, $999.9K in stock awards and $6.7K in other compensation.
Rankings
In 2021, Mark Jacobson, M.A's compensation ranked 2,749th out of 12,405 executives tracked by ExecPay. In other words, MA earned more than 77.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,749 out of 12,405 | 78th |
Division Manufacturing | 1,088 out of 5,494 | 80th |
Major group Chemicals And Allied Products | 427 out of 2,369 | 82nd |
Industry group Drugs | 372 out of 2,090 | 82nd |
Industry Pharmaceutical Preparations | 248 out of 1,537 | 84th |
Pay ratio
| Mark Jacobson, M.A's Pay | $4,794,824 |
|---|---|
| Median Employee's Pay | $690,964 |
| Pay Ratio | 7to 1 |
In 2021, the annual total compensation of Mark Jacobson, M.A was $4,794,824.
The annual total compensation of the median employee at Axsome Therapeutics was $690,964.
The ratio of Mark Jacobson, M.A's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 22, 2022.
MA's colleagues
We found two more compensation records of executives who worked with Mark Jacobson, M.A at Axsome Therapeutics in 2021.